-
News

4th COVID-19 Booster Recommended for those with Chronic Liver Disease

June 21, 2022

The Australian Technical Advisory Group on Immunisation (ATAGI) recommends a fourth COVID-19 vaccine dose for people with a range of immunocompromising conditions including chronic liver diseases such as cirrhosis, autoimmune hepatitis, non-alcoholic fatty liver disease, and alcoholic liver disease.

ATAGI said an extra winter booster should be given four months after the initial booster but should be delayed three months after a confirmed COVID-19 infection has cleared. Any Australian with a chronic, terminal, or severe illness, or those suffering from a significant disability are now eligible for the fourth dose. ATAGI also encourages those over 65 to consider the fourth dose during flu season. This new scheme aims to prevent poor outcomes of COVID-19 for those who are immunocompromised, during the winter months.

ATAGI has advised that the flu vaccine could still be given ahead of the additional booster for patients not yet eligible for a fourth dose.

ATAGI Booster Advice
LiverLine
We are here to answer your queries and support you. Call or chat with us online.
LiverWELL, incorporating Hepatitis Victoria, champions the interests of people affected by or at risk of viral hepatitis and liver disease.

LiverWELL acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community.

We welcome people from all cultures, nationalities and religions. Being inclusive and providing equitable services is our commitment.